The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Blood Pressure Drug Improves Functional Status of Peripheral Artery Disease Patients
February 5th 2014Among patients with peripheral artery disease and intermittent claudication, a daily dose of 10 mg ramipril can improve pain-free treadmill walking times, which are associated with a significant increase in physical functioning.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.
Thyroid Dysfunction Increases Cardiovascular Risks in Diabetic Dialysis Patients
January 24th 2014Though dialysis patients have a greater risk for thyroid disorders due to uremic toxins, protein malnutrition, and inflammation, the prevalence of those disorders and their impact on cardiovascular (CV) events and mortality have not been investigated.
Cardiology Groups Collaborating on Another Set of Hypertension Guidelines
After just releasing new hypertension guidelines, the American Society of Hypertension (ASH) is now collaborating with the American Heart Association (AHA) and the American College of Cardiology (ACC) on another set of guidelines expected to be out by the end of 2014 or early 2015.
Heart Disease Linked to Cognitive Decline in Elderly Postmenopaual Women
A recent study published online in the Journal of the American Heart Association discovered an association between cardiovascular disease (CVD) and cognitive decline in postmenopausal women between the ages of 65 and 79 years old.